EAN 2023: Cutting edge diagnosis and management strategies in neuromuscular disease. - European Medical Journal

EAN 2023: Cutting edge diagnosis and management strategies in neuromuscular disease.

Neurology

This highly informative and thought-provoking symposium was held at EAN 2023 where the latest strategies to diagnose and manage neuromuscular diseases were discussed.

Professor Benedikt Schoser, along with Professor Kristl Claeys and Dr Zoltan Grosz, take the audience through the evolving neuromuscular landscape and the novel strategies that are emerging to help diagnose, monitor and manage patients.

The EAN meeting was intended for HealthCare Professionals only. Content regarding products is aligned with European Summary of Product Characteristics (EU SmPC), if applicable. Please consult product information in your country of practice as information may vary from country to country depending on local approval.

 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given